positive

Career story: “It’s important for me to be able to do work that has a positive impact on people’s lives”

• CSP

Career story: “It’s important for me to be able to do work that has a positive impact on people’s lives”

creativebharatgroup@gmail.com December 20, 2024

Pauliina Nurminen has been working at Planmeca since 2010. She started as a...

Read More Read more about Career story: “It’s important for me to be able to do work that has a positive impact on people’s lives”

Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

• CSP

Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

creativebharatgroup@gmail.com December 17, 2024

Lund, Sweden, 17 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), today...

Read More Read more about Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

Positive Earnings Trends Heading into 2025, S&P 500 Price Targets Rolling In

• Finanicial Market

Positive Earnings Trends Heading into 2025, S&P 500 Price Targets Rolling In

creativebharatgroup@gmail.com December 4, 2024

Positive Earnings Trends Heading into 2025, S&P 500 Price Targets Rolling In Source link

Read More Read more about Positive Earnings Trends Heading into 2025, S&P 500 Price Targets Rolling In

Citycon’s recent credit positive actions acknowledged in S&P Global Rating’s latest assessment

• CSP

Citycon’s recent credit positive actions acknowledged in S&P Global Rating’s latest assessment

creativebharatgroup@gmail.com November 27, 2024

CITYCON OYJ   Investor News   27 November 2024 at 13:40 hrs Citycon acknowledges recent...

Read More Read more about Citycon’s recent credit positive actions acknowledged in S&P Global Rating’s latest assessment

SMT Launches Hydra TAVI System in Hungary, Expands Global Footprint with Positive Early Results

• BWI

SMT Launches Hydra TAVI System in Hungary, Expands Global Footprint with Positive Early Results

creativebharatgroup@gmail.com November 25, 2024

Sahajanand Medical Technologies Ltd. (SMT)   Mumbai, Maharashtra, India:  SMT (Sahajanand Medical Technologies),...

Read More Read more about SMT Launches Hydra TAVI System in Hungary, Expands Global Footprint with Positive Early Results

US Building Permits Decline Slows, Indicating Positive Economic Outlook

• Economy Growth

US Building Permits Decline Slows, Indicating Positive Economic Outlook

creativebharatgroup@gmail.com November 19, 2024

US Building Permits Decline Slows, Indicating Positive Economic Outlook Source link

Read More Read more about US Building Permits Decline Slows, Indicating Positive Economic Outlook

Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization

• CSP

Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization

creativebharatgroup@gmail.com November 19, 2024

  Oslo, 19 November 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX),...

Read More Read more about Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization

Stayble Therapeutics’ STA363 receives positive phase 1b results

• CSP

Stayble Therapeutics’ STA363 receives positive phase 1b results

creativebharatgroup@gmail.com November 13, 2024

Stayble Therapeutics AB (“Stayble” or the “Company”) announces positive results from the Company’s...

Read More Read more about Stayble Therapeutics’ STA363 receives positive phase 1b results

ExpreS2ion and Evaxion announce positive preclinical data for cytomegalovirus (CMV) vaccine program ES2B-I002

• CSP

ExpreS2ion and Evaxion announce positive preclinical data for cytomegalovirus (CMV) vaccine program ES2B-I002

creativebharatgroup@gmail.com November 12, 2024

Hørsholm, Denmark, 12 November 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion...

Read More Read more about ExpreS2ion and Evaxion announce positive preclinical data for cytomegalovirus (CMV) vaccine program ES2B-I002